BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30610812)

  • 1. Clinicopathological characteristics of patients with multiple primary neoplasms-a retrospective analysis.
    Nemes A; Todor N; Nagy V
    J BUON; 2018; 23(6):1846-1854. PubMed ID: 30610812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up protocol for oncological patients at risk of developing multiple primary neoplasms.
    Nemes A; Todor N; Nagy V
    J BUON; 2020; 25(4):2117-2122. PubMed ID: 33099962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple primary malignancies--epidemiological analysis at a single tertiary institution.
    Irimie A; Achimas-Cadariu P; Burz C; Puscas E
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):69-73. PubMed ID: 20361078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study.
    Tanjak P; Suktitipat B; Vorasan N; Juengwiwattanakitti P; Thiengtrong B; Songjang C; Therasakvichya S; Laiteerapong S; Chinswangwatanakul V
    BMC Cancer; 2021 Sep; 21(1):1045. PubMed ID: 34556087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Primary Tumors Originating From the Prostate and Colorectum A Clinical-Pathological and Therapeutic Challenge.
    Dema S; Bota A; Tăban SM; Gheju A; Dema ALC; Croitor A; Barna RA; Popa O; Bardan R; Cumpănaș AA
    Am J Mens Health; 2021; 15(5):15579883211044881. PubMed ID: 34493123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.
    Krahling T; Balassa K; Kiss KP; Bors A; Batai A; Halm G; Egyed M; Fekete S; Remenyi P; Masszi T; Tordai A; Andrikovics H
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):98-104. PubMed ID: 26487696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple malignant tumors.
    Chirila DN; Turdeanu NA; Constantea NA; Coman I; Pop T; Popp RA; Balacescu O; Vesa SC; Ciuce C
    Chirurgia (Bucur); 2013; 108(4):498-502. PubMed ID: 23958092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous and metachronous bilateral breast cancer: A long-term experience.
    Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
    J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients.
    Jiao F; Yao LJ; Zhou J; Hu H; Wang LW
    Asian Pac J Cancer Prev; 2014; 15(1):331-4. PubMed ID: 24528052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple primary malignant neoplasms in patients with esophageal cancer.
    Nagasawa S; Onda M; Sasajima K; Takubo K; Miyashita M
    Dis Esophagus; 2000; 13(3):226-30. PubMed ID: 11206637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of multiple primary neoplasms in daily practicea systematic review of the literature.
    Nemes A; Nagy V
    J BUON; 2018; 23(1):14-18. PubMed ID: 29552753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends.
    Chen HS; Sheen-Chen SM
    Dis Colon Rectum; 2000 Aug; 43(8):1093-9. PubMed ID: 10950007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
    Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
    Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
    Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
    Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous and metachronous cancers in patients with gastric cancer.
    Eom BW; Lee HJ; Yoo MW; Cho JJ; Kim WH; Yang HK; Lee KU
    J Surg Oncol; 2008 Aug; 98(2):106-10. PubMed ID: 18452218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple synchronous and metachronous cancers of the upper aerodigestive tract: a nine-year study.
    Panosetti E; Luboinski B; Mamelle G; Richard JM
    Laryngoscope; 1989 Dec; 99(12):1267-73. PubMed ID: 2601541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous and metachronous head and neck carcinomas.
    Schwartz LH; Ozsahin M; Zhang GN; Touboul E; De Vataire F; Andolenko P; Lacau-Saint-Guily J; Laugier A; Schlienger M
    Cancer; 1994 Oct; 74(7):1933-8. PubMed ID: 8082099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
    Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
    Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.